Recommendations for living donor kidney transplantation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Frutos Miguel Ángel, Crespo Marta, Valentín María de la Oliva, Alonso-Melgar Ángel, Alonso Juana, Fernández Constantino, García-Erauzkin Gorka, González Esther, González-Rinne Ana M, Guirado Lluis, Gutiérrez-Dalmau Alex, Huguet Jorge, Moral José Luis López Del, Musquera Mireia, Paredes David, Redondo Dolores, Revuelta Ignacio, Hofstadt Carlos J Van-der, Alcaraz Antonio, Alonso-Hernández Ángel, Alonso Manuel, Bernabeu Purificación, Bernal Gabriel, Breda Alberto, Cabello Mercedes, Caro-Oleas José Luis, Cid Joan, Diekmann Fritz, Espinosa Laura, Facundo Carme, García Marta, Gil-Vernet Salvador, Lozano Miquel, Mahillo Beatriz, Martínez María José, Miranda Blanca, Oppenheimer Federico, Palou Eduard, Pérez-Saez María José, Peri Lluis, Rodríguez Oscar, Santiago Carlos, Tabernero Guadalupe, Hernández Domingo, Domínguez-Gil Beatriz, Pascual Julio
Аннотация
This Guide for Living Donor Kidney Transplantation (LDKT) has been prepared with the sponsorship of the Spanish Society of Nephrology (SEN), the Spanish Transplant Society (SET), and the Spanish National Transplant Organization (ONT). It updates evidence to offer the best chronic renal failure treatment when a potential living donor is available. The core aim of this Guide is to supply clinicians who evaluate living donors and transplant recipients with the best decision-making tools, to optimise their outcomes. Moreover, the role of living donors in the current KT context should recover the level of importance it had until recently. To this end the new forms of incompatible HLA and/or ABO donation, as well as the paired donation which is possible in several hospitals with experience in LDKT, offer additional ways to treat renal patients with an incompatible donor. Good results in terms of patient and graft survival have expanded the range of circumstances under which living renal donors are accepted. Older donors are now accepted, as are others with factors that affect the decision, such as a borderline clinical history or alterations, which when evaluated may lead to an additional number of transplantations. This Guide does not forget that LDKT may lead to risk for the donor. Pre-donation evaluation has to centre on the problems which may arise over the short or long-term, and these have to be described to the potential donor so that they are able take them into account. Experience over recent years has led to progress in risk analysis, to protect donors' health. This aspect always has to be taken into account by LDKT programmes when evaluating potential donors. Finally, this Guide has been designed to aid decision-making, with recommendations and suggestions when uncertainties arise in pre-donation studies. Its overarching aim is to ensure that informed consent is based on high quality studies and information supplied to donors and recipients, offering the strongest possible guarantees.